Giulia Fabbri, Head of the External ADC Franchise at AstraZeneca, shared a post on LinkedIn:
“I’m humbled and excited to share that I’m starting a new position as Head of the External ADC Franchise at AstraZeneca. I’m deeply grateful for the trust and support from colleagues, mentors, and leadership. In this role, I will lead our global translational medicine strategy for partnered ADC assets – integrating scientific and technological advances with business priorities to translate innovation into patient impact. I’ll also work to unify mechanistic insights across the ADC portfolio to accelerate development and shape our end‑to‑end mechanistic strategy, advancing our ambition to eliminate cancer as a cause of death.
Grateful to my mentors and teammates whose mentorship, support, and trust helped me reach this milestone.”